147 related articles for article (PubMed ID: 2763801)
1. Experimental study on subacute neurotoxicity of methotrexate in cats.
Shibutani M; Okeda R
Acta Neuropathol; 1989; 78(3):291-300. PubMed ID: 2763801
[TBL] [Abstract][Full Text] [Related]
2. Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study.
Kim KH; Park M; Park EY; Gwak HS; Kim SH; Seo JW; Hyun JW; Kim HJ; Dho YS; Shin SH; Yoo H; Chang Wang K
Neurology; 2024 Mar; 102(5):e209167. PubMed ID: 38364192
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-related multifocal axonopathy. Report of an autopsy case.
Shibutani M; Okeda R; Hori A; Schipper H
Acta Neuropathol; 1989; 79(3):333-5. PubMed ID: 2609940
[TBL] [Abstract][Full Text] [Related]
4. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
Becker A; Vezmar S; Linnebank M; Pels H; Bode U; Schlegel U; Jaehde U
Int J Clin Pharmacol Ther; 2007 Sep; 45(9):504-15. PubMed ID: 17907593
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
[TBL] [Abstract][Full Text] [Related]
6. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.
Boogerd W; vd Sande JJ; Moffie D
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1277-83. PubMed ID: 3225584
[TBL] [Abstract][Full Text] [Related]
7. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.
Drachtman RA; Cole PD; Golden CB; James SJ; Melnyk S; Aisner J; Kamen BA
Pediatr Hematol Oncol; 2002; 19(5):319-27. PubMed ID: 12078863
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.
Matsubayashi J; Tsuchiya K; Matsunaga T; Mukai K
Neuropathology; 2009 Apr; 29(2):105-15. PubMed ID: 18627488
[TBL] [Abstract][Full Text] [Related]
9. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
[TBL] [Abstract][Full Text] [Related]
10. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
[TBL] [Abstract][Full Text] [Related]
11. Disseminated necrotizing encephalopathy induced by methotrexate therapy alone.
Asada Y; Kohga S; Sumiyoshi A; Ishikawa M; Nakamura H
Acta Pathol Jpn; 1988 Oct; 38(10):1305-12. PubMed ID: 3218509
[TBL] [Abstract][Full Text] [Related]
12. Pressure-absorption responses to the infusion of fluid into the spinal cord central canal of kaolin-hydrocephalic cats.
Nakamura S; Camins MB; Hochwald GM
J Neurosurg; 1983 Feb; 58(2):198-203. PubMed ID: 6848676
[TBL] [Abstract][Full Text] [Related]
13. The rat in experimental obstructive hydrocephalus.
Hochwald GM; Nakamura S; Camins MB
Z Kinderchir; 1981 Dec; 34(4):403-10. PubMed ID: 7331547
[TBL] [Abstract][Full Text] [Related]
14. Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Lai R; Abrey LE; Rosenblum MK; DeAngelis LM
Neurology; 2004 Feb; 62(3):451-6. PubMed ID: 14872029
[TBL] [Abstract][Full Text] [Related]
15. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Linnebank M; Pels H; Kleczar N; Farmand S; Fliessbach K; Urbach H; Orlopp K; Klockgether T; Schmidt-Wolf IG; Schlegel U
Neurology; 2005 Mar; 64(5):912-3. PubMed ID: 15753437
[TBL] [Abstract][Full Text] [Related]
16. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy.
Suzuki K; Takemura T; Okeda R; Hatakeyama S
Acta Neuropathol; 1984; 65(2):145-9. PubMed ID: 6596829
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of methotrexate-induced stroke-like neurotoxicity.
Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K
Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170
[TBL] [Abstract][Full Text] [Related]
18. Active transport of methotrexate from cerebrospinal fluid in humans.
Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL
Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
[TBL] [Abstract][Full Text] [Related]
19. Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
Satomi K; Yoshida M; Matsuoka K; Okita H; Hosoya Y; Shioda Y; Kumagai MA; Mori T; Morishita Y; Noguchi M; Nakazawa A
Neuropathology; 2014 Aug; 34(4):414-9. PubMed ID: 24661121
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
Li Y; Vijayanathan V; Gulinello M; Cole PD
Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
